凱升控股(00102.HK)2023年總收益3.69億港元 同比減少1%
格隆匯7月10日丨凱升控股(00102.HK)公吿,集團於2023年的2023年總收益為港幣3.69億元,同比減少1%。於2023年,公司擁有人應占虧損為港幣7.4億元,2022年則為公司擁有人應占溢利港幣1180萬元。
於2023年錄得虧損,主要由於(i)物業、經營權及設備確認減值虧損約港幣4.8億元,而2022年則並無錄得有關減值虧損;(ii)於2023年,衍生金融工具公平值虧損約港幣1.69億元,而2022年則約港幣1.4億元;及(iii)財務擔保合約預期信貸虧損於2023年約港幣3.048億元,惟並無於2022年確認財務擔保合約預期信貸虧損。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.